Access to Cannabis for Medical Purposes Regulations (ACMPR)
Definition - What does Access to Cannabis for Medical Purposes Regulations (ACMPR) mean?
The Access to Cannabis for Medical Purposes Regulations, developed in August 2016, are a set of Canadian government regulations that allow approved and licensed patients to possess and use cannabis to treat specific medical illnesses or conditions.
The Access to Cannabis for Medical Purposes Regulations (ACMPR) replaces or provides an update to a couple of failed regulations that fell short in a few areas.
For example, as of March 31, 2014, the Marihuana Medical Access Regulations were repealed and replaced by the Marihuana for Medical Purposes Regulations. Since the Marihuana for Medical Purposes Regulations still had some glitches, the Access to Cannabis for Medical Purposes Regulations quickly came to be.
Hydrolife explains Access to Cannabis for Medical Purposes Regulations (ACMPR)
In order to register as a licensed patient under the ACMPR, firstly the prospective patient must consult with an authorized Health Care Practitioner to decide on treatments. The second step is to get a hold of a medical document drafted by the producer’s Health Care Practitioner that has producer details, such as the name, date of birth, location of practitioner consultation, Health Care Practitioner information, and a healthcare practitioner document authorization to avoid incorrect details.
The third step, after getting a medical document from the authorized health care practitioner, the patient can register as a client with the licensed producer of their choice. To register, the patient has to submit the original medical document and other required information. The fourth and final step in being a licensed patient would be the shipping of the cannabis ordered for medicinal purposes, which would be directly sent by the licensed producer.
Both the ACMPR and Health Canada ban licensed producers to provide patients with cannabis through a storefront or dispensary. In other words, licensed producers cannot supply dispensaries with product. They must sell direct, and only to, patients.
In Canada, the Controlled Drugs and Substances Act, or CDSA, does not allow the possession, trafficking, import, export, or production of controlled substances, including cannabis. However, if the substance is recognized and authorized by the ACMPR or Health Canada regulations, an exception is made.
Even when registered as a licensed producer or patient under the ACMPR regulations, there are some rules users must satisfy. The amount of dried cannabis possessed needs to be lower than 30 times the daily amount stipulated by a Health Care Practitioner or a prescribed 150 grams. For example, if a Health Care Practitioner recommends consumption of 3 grams per day, the licensed patient would be allowed a maximum of 90 grams at any one time (which is the equivalent of 30 days × 3 grams).
However, if the Health Care Practitioner recommends 6 grams per day, the licensed patient would be allowed to possess a maximum of 150 grams at any one time, which would therefore be less than a 30 day supply.